All News

2019

March

Media Release / Mar 18, 2019

Alcon Announces Acquisition of PowerVision, Inc.

Read More
Media Release / Mar 14, 2019

Novartis joins the Global Chagas Disease Coalition and also announces first multinational, prospective, randomized study in people with chronic Chagas cardiomyopathy

Read More
Media Release / Mar 14, 2019

Novartis announces change in Sandoz leadership

Read More
Media Release / Mar 11, 2019

Three winners of 2019 Sandoz Healthcare Access Challenge (HACk) are announced at SXSW

Read More
Media Release / Mar 05, 2019

Novartis Cosentyx® shows superior improvements in psoriasis patients' quality of life versus Janssen's IL-23 Stelara®*

Read More
Media Release / Mar 04, 2019

Novartis data confirm rapid response and high efficacy of Cosentyx® in psoriasis patients for first time in China

Read More

February

Media Release / Feb 28, 2019

Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting

Read More
Media Release / Feb 25, 2019

Novartis issues summary financial information for the Alcon eye care business ahead of shareholder vote on proposed spin-off

Read More
Media Release / Feb 25, 2019

Novartis to pursue transformational therapy to reduce risk of cardiovascular disease in people living with elevated levels of inherited lipoprotein(a)

Read More
Media Release / Feb 13, 2019

Novartis receives FDA approval for Egaten® for the treatment of fascioliasis, a neglected tropical disease

Read More

Pages

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More